Dr. Jaclyn Bosco works with customers to develop strategies for using patient registries and other observational study methods for real-world evidence generation to support the safety and effectiveness of drugs, biologics and biosimilars, and devices. She is experienced in helping customers refine their research questions based on various stakeholder needs, identifying the best approach for capturing data on a global scale as well applying local approaches to address market-specific needs, and designing and executing medical chart review studies, patient registries, and observational comparative effectiveness and safety research studies. She has >10 years of practical experience leading non-interventional research studies across the globe including North America, Europe, and Asia-Pacific regions. Dr. Bosco is responsible for scientific oversight, primarily in the areas of the design, analysis, and interpretation of non-interventional studies of comparative safety and effectiveness of medical treatments. She possesses considerable expertise in the application of epidemiologic methods to studies with de novo data collection, including propensity scoring, instrumental variable methods, bias analysis, and other methods for addressing bias. Dr. Bosco received her PhD in Epidemiology and MPH in Epidemiology and Biostatistics from the Boston University School of Public Health and completed her research fellowship with Dana Farber Cancer Institute/Harvard Medical School. She has published articles in various leading peer-reviewed journals, presented at international and national meetings, reviewed manuscripts and abstracts for high-impact journals and national conferences, co-authored a book chapter, and taught lectures in epidemiologic methods. She is currently a member of the International Society for Pharmacoepidemiology, International Society for Pharmacoeconomics and Outcomes Research, Society for Epidemiologic Research, and American Association of Cancer Research.